Evidence map›Paper›PMID 39396736›Full record

Trial reportBiological psychiatry2025

Noninvasive Modulation of the Subcallosal Cingulate and Depression With Focused Ultrasonic Waves.

Thomas S Riis, Daniel A Feldman, Sarah S Kwon, Lily C Vonesh, Vincent Koppelmans, Jefferson R Brown, Daniela Solzbacher, Jan Kubanek, Brian J Mickey

Erratum issued Registry-linked trialAbstract readClinical Trial, Phase IClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Biological psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07226648 (Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia), which is not on this map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07226648 narecruitingnot on this map

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia: A Blinded Randomized Sham-Controlled Trial

TypeinterventionalSponsorSPIRE Therapeutics Inc.Ran2025 to 2026Enrolled180ConditionsFibromyalgiaArmsFocused Ultrasound
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Brainwaves meet soundwaves: ultrasound stimulation for treating major depressive disorder by targeting the subcallosal cingulate cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Advances in the Clinical Application of Neurostimulation in Major Depression.Advances in experimental medicine and biology · 2026
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Thomas S RiisDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah. Electronic address: tom.riis@utah.edu.
Daniel A FeldmanDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah; Department of Radiology, University of Utah, Salt Lake City, Utah; Department of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Sarah S KwonDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Lily C VoneshDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Vincent KoppelmansDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Jefferson R BrownDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Daniela SolzbacherDepartment of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Jan KubanekDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah; Department of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah.
Brian J MickeyDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah; Department of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, Utah. Electronic address: brian.mickey@utah.edu.

Funding

Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Siemens MAGNETOM Vida 3T MRI ScannerS10OD026788 · OD · UNIVERSITY OF UTAH · PI PARKER, DENNIS L · 2019 to 2019
$2.0M
Noninvasive modulation of deep brain circuits for treatment-resistant depressionR61MH134943 · NIMH · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI KUBANEK, JAN, MICKEY, BRIAN JAMES · 2024 to 2025
$1.7M
Noninvasive Targeted NeuromodulationRF1NS128569 · NINDS · UNIVERSITY OF UTAH · PI KUBANEK, JAN · 2022 to 2022
$1.4M
Ultrasonic Neuromodulation: From Mechanism To Optimal ApplicationR00NS100986 · NINDS · UNIVERSITY OF UTAH · PI KUBANEK, JAN · 2019 to 2021
$729k
NCATS NIH HHS UL1 TR002538NCATS NIH HHS UM1 TR004409NIH HHS S10 OD026788NIMH NIH HHS R61 MH134943NINDS NIH HHS R00 NS100986NINDS NIH HHS RF1 NS128569
6 · The paper itself

Abstract

backgroundSevere forms of depression have been linked to excessive subcallosal cingulate cortex (SCC) activity. Stimulation of the SCC with surgically implanted electrodes can alleviate depression, but current noninvasive techniques cannot directly and selectively modulate deep targets. We developed a new noninvasive neuromodulation approach that can deliver low-intensity focused ultrasonic waves to the SCC.

methodsTwenty-two individuals with treatment-resistant depression participated in a randomized, double-blind, sham-controlled study. Ultrasonic stimulation was delivered to the bilateral SCC during concurrent functional magnetic resonance imaging to quantify target engagement. Mood state was measured with the Sadness subscale of the Positive and Negative Affect Schedule before and after 40 minutes of real or sham SCC stimulation. Change in depression severity was measured with the 6-item Hamilton Depression Rating Scale at 24 hours and 7 days.

resultsFunctional magnetic resonance imaging demonstrated a target-specific decrease in SCC activity during stimulation (p = .028, n = 16). In 7 of 16 participants, SCC neuromodulation was detectable at the individual participant level with a single 10-minute scan (p < .05, small-volume correction). Mood and depression scores improved more with real than with sham stimulation. In the per-protocol sample (n = 19), real stimulation was superior to sham for 6-item Hamilton Depression Rating Scale scores at 24 hours and for Sadness scores (both p < .05, d > 1). Nonsignificant trends were found in the intent-to-treat sample.

conclusionsThis small pilot study indicates that ultrasonic stimulation modulates SCC activity and can rapidly reduce depressive symptoms. The capability to noninvasively and selectively target deep brain areas creates new possibilities for the future development of circuit-directed therapeutics and for the analysis of deep-brain circuit function in humans.

Indexed as

Depressive Disorder, Treatment-ResistantGyrus CinguliUltrasonic TherapyUltrasonic WavesAdultDouble-Blind MethodFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedTreatment OutcomeDeep brain stimulationDepressionNeuromodulationSubcallosal cingulateSubgenual cingulateUltrasound

Identifiers

PMID39396736
PMCPMC11954670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.